Économie

Jannik Sinner accepts three-month doping ban, avoids missing any Grand Slam

The world No.1 settles with WADA over two positive tests for anabolic steroid, a case that has sparked accusations of double standards across tennis.

5 min
Jannik Sinner accepts three-month doping ban, avoids missing any Grand Slam
The world No.1 settles with WADA over two positive tests for anabolic steroid, a case that has sparked accusations of doCredit · ATP Tour

Key facts

  • Jannik Sinner accepted a three-month ban in a settlement with the World Anti-Doping Agency.
  • The ban runs from February 9 to May 4, 2025, allowing him to play the French Open starting May 25.
  • Sinner tested positive for Clostebol in March 2024; the ITIA initially ruled accidental contamination.
  • WADA appealed the ITIA decision, seeking at least a one-year suspension.
  • Sinner won the 2025 Australian Open in January before the settlement was reached.
  • The settlement means Sinner misses no Grand Slam tournaments.
  • Top players including Novak Djokovic, Nick Kyrgios, and Stan Wawrinka have criticized the outcome.

A settlement reached under the shadow of a looming CAS hearing

Jannik Sinner, the 23-year-old Italian world No.1, has accepted a three-month suspension from tennis in a settlement with the World Anti-Doping Agency, bringing an end to a case that had hung over him for nearly a year. The agreement, announced Saturday, resolves WADA’s appeal against an earlier decision by the International Tennis Integrity Agency not to suspend Sinner after he twice tested positive for the banned anabolic steroid Clostebol. WADA had sought a ban of at least one year and had taken the case to the Court of Arbitration for Sport in Lausanne. Sinner, who had maintained his innocence throughout, said in a statement that he accepted the sanction to avoid a prolonged legal battle. “This case had been hanging over me now for nearly a year and the process still had a long time to run with a decision maybe only at the end of the year,” he said.

How a massage led to a positive doping test

The positive tests, from March 2024, revealed trace amounts of Clostebol, an anabolic steroid often used in topical creams. Sinner’s explanation, accepted by both the ITIA and WADA, was that the substance entered his system through a massage from a trainer who had used a Clostebol-containing product after cutting his own finger. WADA acknowledged that Sinner did not intend to cheat and that the exposure provided no performance-enhancing benefit. “WADA accepts the athlete’s explanation for the cause of the violation as outlined in the first instance decision,” the agency said in its announcement. “WADA accepts that Mr. Sinner did not intend to cheat, and that his exposure to Clostebol did not provide any performance-enhancing benefit and took place without his knowledge as the result of negligence of members of his entourage.” However, WADA noted that under the code and CAS precedent, an athlete bears responsibility for the negligence of his entourage.

A timeline that spares Sinner’s Grand Slam ambitions

The three-month ban runs from February 9 to May 4, 2025, meaning Sinner will miss the Indian Wells and Miami Open “Sunshine Double,” as well as tournaments in Monte Carlo and Madrid. Crucially, he will be eligible to return for the Italian Open in Rome and the French Open, which begins May 25. Sinner won the Australian Open in January, his third Grand Slam title, and will not miss any of the four majors. The timing of the settlement has drawn sharp criticism from fellow players. Novak Djokovic called the outcome “too coincidental,” suggesting preferential treatment. Nick Kyrgios declared it “a sad day for tennis,” while Stan Wawrinka said he no longer believes in clean sport. Alexander Zverev, whom Sinner defeated in the Australian Open final, argued that if Sinner was innocent, he should not be banned at all.

The double-standard debate reignites

The case has revived accusations of a two-tier system in tennis anti-doping. Critics point out that Sinner’s positive tests were not made public until after he successfully appealed a provisional suspension, allowing him to compete in and win the 2024 US Open. Other players with similar doping cases have faced immediate public disclosure and harsher sanctions. Sinner, in an interview with Italian state television, acknowledged the emotional toll. “I remember before this year’s Australian Open, I was really unhappy. I felt uncomfortable in the locker room and in the dining area. The way other players looked at me had changed,” he said. “I told myself, ‘Maybe after the Australian Open, I should take a break.’” He added that accepting the ban was difficult because he knew he had done nothing wrong, but legal advice warned of a potentially worse outcome if the case went to CAS.

WADA’s rationale and the legal framework

WADA formally withdrew its appeal to CAS as part of the settlement. In its statement, the agency said that based on the “unique set of facts” of the case, a three-month suspension was appropriate. It also noted that it did not seek disqualification of any results beyond those already imposed by the first-instance tribunal. The decision has been met with skepticism from some anti-doping experts. Professor Liu Yongsong of Hong Kong Baptist University, in an interview with SBS, questioned the consistency of WADA’s approach. The settlement avoids a full CAS hearing, which would have examined the evidence in detail and could have set a clearer precedent for future cases.

Sinner’s return and the cloud that remains

Sinner is scheduled to return to competition at the Italian Open in Rome, a home tournament where he will likely face a mixed reception. He said he hopes no innocent person has to go through what he experienced. “I don’t want to respond to the criticism. Everyone is entitled to their opinion. For me, what matters is that I know the truth,” he said. The case leaves unresolved questions about the effectiveness and fairness of tennis’s anti-doping system. While Sinner’s ban is now set, the sport must grapple with the perception that its top star received lenient treatment — a perception that, fair or not, threatens to undermine confidence in the integrity of the game.

The bottom line

  • Jannik Sinner accepted a three-month ban for two positive Clostebol tests, avoiding a longer suspension that WADA had sought.
  • The ban runs from February 9 to May 4, 2025, allowing him to compete in the French Open and all other Grand Slams.
  • WADA acknowledged Sinner did not intend to cheat but held him responsible for his entourage’s negligence.
  • The settlement has sparked accusations of double standards from top players including Djokovic, Kyrgios, and Wawrinka.
  • Sinner’s positive tests were not disclosed until after he won the 2024 US Open, fueling criticism of the process.
  • The case highlights ongoing tensions in tennis over anti-doping enforcement and perceptions of favoritism.
Galerie
Jannik Sinner accepts three-month doping ban, avoids missing any Grand Slam — image 1Jannik Sinner accepts three-month doping ban, avoids missing any Grand Slam — image 2Jannik Sinner accepts three-month doping ban, avoids missing any Grand Slam — image 3Jannik Sinner accepts three-month doping ban, avoids missing any Grand Slam — image 4Jannik Sinner accepts three-month doping ban, avoids missing any Grand Slam — image 5Jannik Sinner accepts three-month doping ban, avoids missing any Grand Slam — image 6
More on this